跳至主要内容
临床试验/NCT03207893
NCT03207893已完成不适用

Benefits of Adding Continuous Glucose Monitoring to Glycemic Load, Exercise, and Monitoring of Blood Glucose (GEM) for Adults With Type 2 Diabetes - Phase 2

University of Virginia2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2018年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
2
主要终点
HbA1c

研究概览

简要总结

The purpose of this study is to determine if the use of continuous glucose monitoring with the GEM lifestyle modification program (Glycemic load, Exercise and Monitoring glucose) will result in better diabetes control than routine care.

详细描述

Type 2 diabetes (t2d) is a major epidemic of the developing world which has huge fiscal consequences and many physical complications. It is thought to be brought on in part by contemporary easy access to high energy foods and reduced physical activity, resulting in increased belly fat that culminates in growing insulin resistance and subsequent hyperglycemia. Because of ease and efficacy of medication management, t2d is primarily managed with ever-escalating medication use, which significantly contributes to medical cost and possibly the progression of the disease itself.

An effective supplement or alternative to medication management is lifestyle modification. Conventional lifestyle modification focuses on reducing body fat and insulin resistance through weight reduction from caloric restriction and aerobic exercise. Sustained routine application of this approach is limited because some individuals do not need to lose weight, some do not want to lose weight, others cannot lose weight, and when successful, lifelong weight reduction is difficult to sustain. A useful paradigm shift in lifestyle treatment of t2d might be to go from reducing calories to reducing postprandial glucose (PPG), the primary contributor to glycosylated hemoglobin (HbA1c).

PPG spikes can be prevented by replacing high with low glycemic load foods and dampened by engaging in postprandial physical activity. This is exemplified by the integrated Glycemic load, Exercise and Monitoring glucose (GEM) program. It promotes choices of low glycemic load foods and increased physical activity, directed by glucose monitoring feedback. Glucose feedback can: 1) educate people as to what food choices minimize PPG and what physical activity choices directly lower PPG, 2) activate individuals when glucose is out of their desired range by alerting them to make choices to lower high glucose or raise low glucose, and 3) motivate individuals to repeat those choices that resulted in desirable glucose consequences. The educating, activating and motivating benefits of glucose feedback are thought to be qualitatively and quantitatively enhanced through continuous glucose monitoring (CGM).

It is hypothesized that, compared to Routine Care (RC), GEM with CGM (GEM+CGM) administered to adults with t2d who are failing with oral medication management will result in better diabetes control (lower HbA1c), reduced medication management (less medication), and better psychological functioning (e.g. greater sense of empowerment) in the short term (3 month follow-up). Further, it is hypothesized that their reduction in HbA1c will be driven by a reduction in PPG.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes
  • Between the ages of 21 and 80
  • Failed on an oral medication regimen (HbA1c > 7.5%).

排除标准

  • Takes insulin
  • Took medications in the last 3 months that impede weight loss (e.g., prednisone)
  • Pregnant or contemplating pregnancy in the next 12 months
  • Conditions that preclude increasing physical activity (e.g. severe neuropathy, cardiovascular disease, chronic obstructive pulmonary disease/emphysema, osteoarthritis, stroke)
  • Severe mental disease (e.g. manic depressive illness, severe depression, or active substance abuse)
  • Undergoing treatment for cancer
  • History of lactic acidosis
  • Marked renal impairment (eGFR < 45; stage 3b chronic kidney disease)
  • Takes psychotropic medications that raise blood glucose (e.g. atypical antipsychotics)
  • Cannot read English.

结局指标

主要结局

HbA1c

时间窗: baseline, 3 months post-intervention

Change in HbA1c measured via blood test

Medication changes

时间窗: baseline, 3 months post-intervention

Changes in prescribed medications (type and/or dosage)

次要结局

  • change in psychological functioning (depression questionnaire)(baseline, 3 months post-intervention)
  • Exercise (Fitbit)(baseline, 3 months post-intervention)
  • change in psychological functioning (diabetes knowledge questionnaire)(baseline, 3 months post-intervention)
  • change in food choices (ASA24 survey)(baseline, 3 months post-intervention)
  • change in psychological functioning (quality of life questionnaire)(baseline, 3 months post-intervention)
  • Psychological functioning (PAID questionnaire)(baseline, 3 months post-intervention)
  • change in food choices (energy bar selection)(baseline, 3 months post-intervention)
  • change in psychological functioning (dietary habits questionnaire)(baseline, 3 months post-intervention)
  • change in psychological functioning (numeracy questionnaire)(baseline, 3 months post-intervention)
  • change in psychological functioning (empowerment questionnaire)(baseline, 3 months post-intervention)
  • change in psychological functioning (attitude towards glucose monitoring questionnaire)(baseline, 3 months post-intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Cox, PhD

Professor, Departments of Psychiatry, Internal Medicine and Ophthalmology

University of Virginia

研究点 (2)

Loading locations...

相似试验

Benefits of Continuous Glucose Monitoring With GEM... | 临床试验